TD Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,200
Closed -$576K 1406
2024
Q3
$576K Buy
15,200
+3,700
+32% +$152K ﹤0.01% 1281
2024
Q2
$520K Buy
11,500
+2,400
+26% +$110K ﹤0.01% 1271
2024
Q1
$441K Sell
9,100
-300
-3% -$14.7K ﹤0.01% 1314
2023
Q4
$504K Buy
9,400
+800
+9% +$40.5K ﹤0.01% 1298
2023
Q3
$504K Buy
8,600
+1,200
+16% +$75K ﹤0.01% 1280
2023
Q2
$466K Buy
7,400
+3,400
+85% +$217K ﹤0.01% 1280
2023
Q1
$252K Buy
+4,000
New +$239K ﹤0.01% 1360
2022
Q1
Sell
-9,700
Closed -$982K 1512
2021
Q4
$982K Sell
9,700
-21,000
-68% -$2.09M ﹤0.01% 1276
2021
Q3
$2.83M Buy
30,700
+800
+3% +$77K ﹤0.01% 982
2021
Q2
$2.85M Buy
29,900
+1,400
+5% +$141K ﹤0.01% 987
2021
Q1
$2.78M Hold
28,500
﹤0.01% 1005
2020
Q4
$2.2M Sell
28,500
-28,500
-50% -$2.2M ﹤0.01% 1016
2020
Q3
$4.2M Sell
57,000
-14,000
-20% -$1.12M 0.01% 747
2020
Q2
$5.21M Buy
71,000
+3,600
+5% +$282K 0.01% 649
2020
Q1
$3.89M Buy
67,400
+31,200
+86% +$2.17M 0.01% 674
2019
Q4
$2.84M Buy
+36,200
New +$2.67M ﹤0.01% 845

Other funds holding USNA

TD Asset Management's USNA Position: Q4 2024 in Review

TD Asset Management sold out of Usana Health Sciences (USNA) in Q4 2024, closing a stake of 15,200 shares — an estimated $576K sold.

TD Asset Management first reported a position in USNA in Q4 2019 and held it in 16 quarters. The position peaked at $5.21M in Q2 2020. 152 funds tracked by Wall St. Rank hold USNA as of Q4 2024.

  • TD Asset Management reported no remaining Usana Health Sciences position as of Q4 2024 after selling out during the quarter.
  • TD Asset Management sold 15,200 Usana Health Sciences shares in Q4 2024, an estimated $576K.
  • TD Asset Management first reported a position in Usana Health Sciences in Q4 2019 and held it in 16 quarters.
  • TD Asset Management's Usana Health Sciences position peaked at $5.21M in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2024.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.